Amvuttra Injection
Product Images NDC 71336-1003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Amvuttra (NDC 71336-1003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alnylam Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (Amvuttra 01)

Image (Amvuttra 01)
This appears to be a list of words related to a needle and syringe. However, without further context or information, it is difficult to provide a more specific description or purpose for the text.*
FDA Label Image

Image (Amvuttra 02)

Image (Amvuttra 02)
FDA Label Image

Image (Amvuttra 03)

Image (Amvuttra 03)
FDA Label Image

Image (Amvuttra 04)

Image (Amvuttra 04)
FDA Label Image

Image (Amvuttra 05)

Image (Amvuttra 05)
FDA Label Image

Image (Amvuttra 06)

Image (Amvuttra 06)
FDA Label Image

Image (Amvuttra 07)

Image (Amvuttra 07)
FDA Label Image

Chemical Structure (Amvuttra 08)

Chemical Structure (Amvuttra 08)
FDA Label Image

Chemical Formula (Amvuttra 09)

Chemical Formula (Amvuttra 09)
FDA Label Image

Figure 1 (Amvuttra 10)

Figure 1 (Amvuttra 10)
This appears to be a table showing the results of a study comparing a placebo group to a group taking a drug called AMVUTTRA. The table shows the LS Mean (SE) Change in mNIS+7 (a measurement of disease severity) for both groups, the number of participants evaluated, and the statistical significance of the results. Unfortunately, there is not enough information to fully interpret the table, as important context such as the purpose of the study or the condition being treated is missing.*
FDA Label Image

Figure 2 (Amvuttra 11)

Figure 2 (Amvuttra 11)
The text appears to be a chart or table without a clear context. It is not possible to provide a useful description without more information.*
FDA Label Image

Figure 3 (Amvuttra 12)

Figure 3 (Amvuttra 12)
FDA Label Image

Figure 4 (Amvuttra 13)

Figure 4 (Amvuttra 13)
FDA Label Image

Principal Display Panel (25 mg Syringe Carton)

Principal Display Panel (25 mg Syringe Carton)
Description: Vutrisiran injection is a medication that is administered subcutaneously by healthcare professionals only. It contains 25 mg/0.5 ml and the lot number is x0000000K with an expiry date MMA YYYY. The text contains some additional not-available information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.